Royal Bank of Canada’s Vaccinex, Inc. Common Stock VCNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-37
| Closed | – | – | 7391 |
|
|
2024
Q3 | $0 | Sell |
37
-2
| -5% | -$11 | ﹤0.01% | 7642 |
|
|
2024
Q2 | $0 | Hold |
39
| – | – | ﹤0.01% | 7671 |
|
|
2024
Q1 | $0 | Buy |
39
+18
| +86% | +$156 | ﹤0.01% | 7740 |
|
|
2023
Q4 | $0 | Hold |
21
| – | – | ﹤0.01% | 7703 |
|
|
2023
Q3 | $0 | Sell |
21
-1
| -5% | -$51 | ﹤0.01% | 7731 |
|
|
2023
Q2 | $1K | Buy |
22
+2
| +10% | +$166 | ﹤0.01% | 7122 |
|
|
2023
Q1 | $2K | Sell |
20
-5
| -20% | -$549 | ﹤0.01% | 6820 |
|
|
2022
Q4 | $3K | Sell |
25
-1
| -4% | -$124 | ﹤0.01% | 6885 |
|
|
2022
Q3 | $3K | Buy |
26
+1
| +4% | +$196 | ﹤0.01% | 6943 |
|
|
2022
Q2 | $6K | Hold |
25
| – | – | ﹤0.01% | 6601 |
|
|
2022
Q1 | $7K | Buy |
+25
| New | +$6.91K | ﹤0.01% | 7142 |
|
|
2021
Q4 | – | Sell |
-5
| Closed | -$2K | – | 7966 |
|
|
2021
Q3 | $2K | Buy |
+5
| New | +$2.5K | ﹤0.01% | 7375 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7750 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7762 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7347 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7009 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6976 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7109 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7198 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7226 |
|
Other funds holding VCNX
Royal Bank of Canada's VCNX Position: Q4 2024 in Review
Royal Bank of Canada sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2024, closing a stake of 37 shares.
Royal Bank of Canada first reported a position in VCNX in Q3 2021 and held it in 12 quarters. The position peaked at $7K in Q1 2022. 1 fund tracked by Wall St. Rank holds VCNX as of Q4 2024.
- Royal Bank of Canada reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Royal Bank of Canada sold 37 Vaccinex, Inc. Common Stock shares in Q4 2024.
- Royal Bank of Canada first reported a position in Vaccinex, Inc. Common Stock in Q3 2021 and held it in 12 quarters.
- Royal Bank of Canada's Vaccinex, Inc. Common Stock position peaked at $7K in Q1 2022.
- 1 fund tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2024.
Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.